Therapeutic Asset Ratings

480 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Epirubicin Solid Tumor	Mirati Therapeutics Inc.	P3	B (58)
Olaparib Solid Tumor	Hebei Medical University Fourth Hospital	P3	B (58)
Pelabresib Solid Tumor	Novartis Pharmaceuticals	P3	B (58)
Pembrolizumab Solid Tumor	Mirati Therapeutics Inc.	P3	B (58)
TRASTUZUMAB Solid Tumor	Jiangsu HengRui Medicine Co., Ltd.	P3	B (58)
Benadryl Solid Tumor	Hellenic Society of Hematology	P2	B (58)
Everolimus Solid Tumor	Uppsala University Hospital	P2	B (58)
Entrectinib Solid Tumor	Cancer Research UK	P2/3	B (58)
PROPOFOL Solid Tumor	Hong Kong Children's Hospital	P4	B (56)
Vancomycin Solid Tumor	Hospital Universitari Vall d'Hebron Research Institute	P4	B (56)
Cobimetinib Solid Tumor	Helsinki University Central Hospital	P2	B (56)
Pyrotinib Solid Tumor	InxMed (Shanghai) Co., Ltd.	P2	B (56)
rc48-adc Solid Tumor	InxMed (Shanghai) Co., Ltd.	P2	B (56)
Tislelizumab Solid Tumor	InxMed (Shanghai) Co., Ltd.	P2	B (56)
Sevoflurane Solid Tumor	Hong Kong Children's Hospital	P4	CCC (55)
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER Solid Tumor	Elevation Oncology	P2	CCC (55)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Solid Tumor	University of California, San Diego	P2	CCC (55)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Solid Tumor	Mohammed Milhem	P2	CCC (55)
TAMOXIFEN Solid Tumor	DR. DIANE CHISESI NFS. MD. PHD.	P2	CCC (55)
Trastuzumab Emtansine Solid Tumor	Seoul National University Bundang Hospital	P2	CCC (55)
Evomela Solid Tumor	Jonsson Comprehensive Cancer Center	P1/2	CCC (55)
Surufatinib Solid Tumor	Hutchmed	P1/2	CCC (55)
Fluzoparib Solid Tumor	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P3	CCC (54)
Immunoglobulin G1 [de-448-lysine], anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 ?1-chain) fusion protein with peptide linker (GGGGS)2 fusion protein with immunoglobulin anti-(human epidermal growth factor receptor HER3) (human clone HER3.H3 single-chain variable fragment VH-(GGGGS)3-VL), complex with human-mouse monoclonal C225 ?-chain, dimer, 214??,214???,222,222?,228,228?,231,231?-octakis(thioether) with (2S)-N-(carboxymethyl)-2-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-?-alanylglycylglycyl-L-phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1-methyl-2-oxoethoxy]methyl]glycinamide Solid Tumor	Sichuan Baili Pharmaceutical Co., Ltd.	P2	CCC (54)
Shr-A1811 Solid Tumor	Haihua Yuan	P2	CCC (54)

Showing 26 to 50 of 480 assets

PreviousPage 2 of 20Next